About NovaLign Orthopaedics
NovaLign Orthopaedics is a Healthcare company based in Memphis (United States) founded in 2005, and was acquired by Sonoma Orthopedics in February 2011. Minimally invasive implants for long bone fractures are developed. NovaLign Orthopaedics has raised $10 million across 1 funding round from investors including Sonoma Orthopedics, Versant Ventures and Accuitive Medical Ventures. Its chief executive, as recorded, is Jeff Roberts. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Therapies. Its competitors include Biomet, Treace Medical Concepts and IlluminOss Medical; 2 of its 3 listed competitors have raised funding.
Company details
NovaLign Orthopaedics(known as OsteoLign till 2009) develops minimally invasive products for treating long bone fractures like those of bones in the thigh, shin, and calf. It makes Intramedullary fixation system, an FDA cleared system of implants and instruments for humerus, tibia, and femoral fractures that allow less invasive fixation without affecting surrounding joints; and Extra-capsular intramedullary device that allows a surgeon to repair a long bone fracture. Novalign was acquired by Sonoma Orthopaedics in 2011
- Headquarters Memphis, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website novalign.com
- Social LinkedIn
- Acquired by Sonoma Orthopedics (Feb 2011)
- Total Equity Funding$10M (USD)
in 1 rounds
- Latest Funding Round$10M (USD), Series B
Jul 2007
- InvestorsSonoma Orthopedics
& 3 more
- Acquired bySonoma Orthopedics
(Feb 2011)
Funding Insights of NovaLign Orthopaedics
NovaLign Orthopaedics has successfully raised a total of $10M through 1 strategic funding round. The most recent funding activity was a Series B round of $10 million completed in July 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $10M
- Total Rounds 1
- Last Round Series B — $10M
- First Round $10M
(Jul 2007)
- Investors Count 3
All 1 funding rounds of NovaLign Orthopaedics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2007 | $10M | Series B | – | – |
4 investors in total: 4 institutional.
Investors in NovaLign Orthopaedics
NovaLign Orthopaedics has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Sonoma Orthopedics, Versant Ventures and Accuitive Medical Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999. | versantventures.com | |||
Early-stage US healthcare investments are made by Accuitive Medical Ventures. | amvpartners.com | Duluth, United States | ||
Venture capital fund focused on early-stage healthcare startups | svhealthinvestors.com | Boston, United States | ||
Fracture fixation devices for ankle, clavicle, and wrist are developed. | 2005 | sonomaorthopedics.com | Buffalo Grove, United States |
Investor details for NovaLign Orthopaedics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of NovaLign Orthopaedics
1 people are tracked at NovaLign Orthopaedics (1 in leadership).
| Name | Role | Group |
|---|---|---|
Jeff Roberts | CEO & President | Leadership |
Complete people profiles for NovaLign Orthopaedics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of NovaLign Orthopaedics
3 dated milestones of NovaLign Orthopaedics across 6 years, from founding to its latest funding, stage changes and deals.
- Founded NovaLign Orthopaedics is founded.
- Funding First funding round of $10.0M.
- Exit Acquired by Sonoma Orthopedics.
Competitors of NovaLign Orthopaedics
NovaLign Orthopaedics has 3 listed competitors in our database, 2 of them funded. They include Biomet, Treace Medical Concepts and IlluminOss Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biomet.com | 1977 | Warsaw, United States | 3,664 | Orthopedic surgical and non-surgical products are designed and distributed. | ||
| treace.com | 2013 | Ponte Vedra Beach, United States | $15M | 516 | Orthopedic foot and ankle correction systems are developed and offered. | |
| illuminoss.com | 2007 | East Providence, United States | $62.47M | 21 | Minimally invasive orthopedic systems for bone fracture stabilization are developed. |
Detailed competitors of NovaLign Orthopaedics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Orthopedics
3 companies that operate in the same segment as NovaLign Orthopaedics (Orthopedics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Novalign Orthopaedics
Complete news archive for NovaLign Orthopaedics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NovaLign Orthopaedics
NovaLign Orthopaedics was founded in 2005 and raised its 1st funding round 2 years after it was founded.
NovaLign Orthopaedics is headquartered in Memphis, United States. It is registered at Memphis, Tennessee, United States.
Jeff Roberts is the CEO of NovaLign Orthopaedics, as recorded in our data.
NovaLign Orthopaedics is a funded company, having raised a total of $10M across 1 funding round to date. The company's 1st funding round was a Series B of $10M, raised on Jul 2007.
NovaLign Orthopaedics(known as OsteoLign till 2009) develops minimally invasive products for treating long bone fractures like those of bones in the thigh, shin, and calf. It makes Intramedullary fixation system, an FDA cleared system of implants and instruments for humerus, tibia, and femoral fractures that allow less invasive fixation without affecting surrounding joints; and Extra-capsular intramedullary device that allows a surgeon to repair a long bone fracture. Novalign was acquired by Sonoma Orthopaedics in 2011.
NovaLign Orthopaedics's top competitors include Treace Medical Concepts, IlluminOss Medical and Biomet.
NovaLign Orthopaedics has 4 investors. Key investors include Sonoma Orthopedics, Versant Ventures, Accuitive Medical Ventures, and SV Health Investors.
Yes. NovaLign Orthopaedics was acquired by Sonoma Orthopedics in February 2011.